Mentor is expected to operate as a stand-alone business unit reporting through Ethicon, a Johnson & Johnson company and a provider of suture, mesh and other products for a wide range of surgical procedures.
Gary Pruden, company group chairman of Johnson & Johnson, said: “Mentor will become the cornerstone of a broader Johnson & Johnson strategy for aesthetic medicine – serving both consumers and medical professionals.
“We will use our combined strengths and experience to build an aesthetic business that capitalizes on Johnson & Johnson’s broad-based commercial capabilities, worldwide surgical care footprint, and clinical scientific capabilities.”